Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Phar...
FDA Recall #D-0468-2024 — Class III — April 9, 2024
Product Description
Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13
Reason for Recall
Cross Contamination with Other Products
Recalling Firm
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. — Tokushima, N/A
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Product Quantity
N/A
Distribution
USA nationwide.
Code Information
Lot # AMS00223A, Exp 07/31/2025
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.